会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 4. 发明授权
    • SGLT-2 inhibitors, methods of making them, and uses thereof
    • SGLT-2抑制剂,其制备方法及其应用
    • US08575114B2
    • 2013-11-05
    • US13052171
    • 2011-03-21
    • Shuang LiuCheng Guo
    • Shuang LiuCheng Guo
    • A01N43/04A61K31/70C07H5/04C07H5/06
    • A61K31/706
    • The present invention relates to compounds which are inhibitors of sodium dependent glucose co-transporter-2 (SGLT-2). These compounds are used in the treatment of various disorders, including diabetes, impaired glucose tolerance, insulin resistance, retinopathy, nephropathy, neuropathy, cataracts, hyperglycemia, hyperinsulinemia, hyperchlolesterolemia, elevated blood level of free fatty acids or glycerol, hyperlipidemia, hypertriglyceridemia, obesity, wound healing, tissue ischemia, atherosclerosis, and hypertension. These compounds and compositions are also useful for treating and preventing kidney stones, hyperuricemia, gout, and hyponatremia. Methods of making these compounds are also described in the present invention.
    • 本发明涉及作为钠依赖性葡萄糖共转运体-2(SGLT-2)抑制剂的化合物。 这些化合物用于治疗各种疾病,包括糖尿病,葡萄糖耐量降低,胰岛素抵抗,视网膜病变,肾病,神经病,白内障,高血糖症,高胰岛素血症,高胆固醇血症,游离脂肪酸或甘油血液水平升高,高脂血症,高甘油三酯血症,肥胖 伤口愈合,组织缺血,动脉粥样硬化和高血压。 这些化合物和组合物还可用于治疗和预防肾结石,高尿酸血症,痛风和低钠血症。 制备这些化合物的方法也在本发明中描述。
    • 10. 发明授权
    • Chelants and macrocyclic metal complex radiopharmaceuticals thereof
    • 螯合剂及其大环金属络合物放射性药物
    • US07319149B2
    • 2008-01-15
    • US10864792
    • 2004-06-09
    • Shuang Liu
    • Shuang Liu
    • C07D401/02
    • C07F13/005A61K51/0478A61K51/0482C07D213/81C07D213/82C07F9/58
    • Chelants and macrocyclic metal complexes thereof, methods of preparing the chelants and macrocyclic metal complexes, and radiopharmaceutical compositions comprising the macrocyclic metal complexes are disclosed. Methods of using the macrocyclic metal complexes as radiopharmaceuticals for the diagnosis of cardiovascular disorders, infectious diseases and cancer are also disclosed. Chelants as bifunctional chelators (BFCs) for the radiolabeling of target-specific biomolecules, such as proteins, peptides, peptidomimetics, non-peptide receptor ligands, enzyme inhibitors, and enzyme substrates are disclosed. Methods of using macrocyclic metal complexes containing the chelant-biomolecule conjugates as target-specific diagnostic radiopharmaceuticals that selectively localize at sites of disease and allow an image to be obtained of the loci using gamma scintigraphy are disclosed. Methods of use of the radiopharmaceuticals as imaging agents for the diagnosis of cardiovascular disorders, such as thromboembolic disease or atherosclerosis, infectious disease and cancer are further disclosed.
    • 公开了螯合剂及其大环金属络合物,制备螯合剂和大环金属配合物的方法,以及包含大环金属络合物的放射性药物组合物。 还公开了将大环金属络合物用作放射性药物用于诊断心血管疾病,感染性疾病和癌症的方法。 公开了用于靶标特异性生物分子例如蛋白质,肽,肽模拟物,非肽受体配体,酶抑制剂和酶底物的放射性标记的双功能螯合剂(BFC)的螯合剂。 公开了使用含有螯合剂 - 生物分子共轭物的大环金属络合物作为靶向特异性诊断放射性药物的方法,其在疾病部位选择性定位并允许使用γ闪烁扫描获得基因座的图像。 进一步公开了使用放射性药物作为诊断心血管疾病如血栓栓塞性疾病或动脉粥样硬化,感染性疾病和癌症的显像剂的方法。